GS
DNA icon

GTS Securities’s Ginkgo Bioworks DNA Stock Holding History

GTS Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,086
Closed -$61K – 4133
2024
Q2 		$81.3K Buy
6,086
+4,411
+263% +$132K ﹤0.01% 3649
2024
Q1 		$77.7K Sell
1,675
-1,812
-52% -$93.8K ﹤0.01% 3572
2023
Q4 		$236K Sell
3,487
-1,322
-27% -$80.9K ﹤0.01% 3425
2023
Q3 		$348K Sell
4,809
-829
-15% -$66.3K ﹤0.01% 2938
2023
Q2 		$419K Buy
+5,638
New +$334K 0.01% 737

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GTS Securities's DNA Position: Q3 2024 in Review

GTS Securities sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 6,086 shares — an estimated $61K sold.

GTS Securities first reported a position in DNA in Q2 2023 and held it in 5 quarters. The position peaked at $419K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • GTS Securities reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 6,086 Ginkgo Bioworks shares in Q3 2024, an estimated $61K.
  • GTS Securities first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 5 quarters.
  • GTS Securities's Ginkgo Bioworks position peaked at $419K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.